Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06408051
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2024-05-06
Brief Title:
Efficacy of 200 IU OnabotulinumtoxinA Botulinum Toxin Type A in Patients With Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment A Retrospective Analysis
Sponsor:
Hisar Intercontinental Hospital
Organization:
Hisar Intercontinental Hospital
Study Overview
Official Title:
Efficacy of 200 IU OnabotulinumtoxinA Botulinum Toxin Type A in Patients With Idiopathic
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aimed to assess the efficacy and safety of onabotulinumtoxinA botulinum toxin type A in patients with idiopathic overactive bladder OAB and urinary incontinence who had previously failed to respond to anticholinergic treatment Additionally we examined the impact of significant reductions in bladder wall thickness on therapeutic outcomes
Detailed Description:
The efficacy of OnabotulinumtoxinA was investigated in patients who attended urology outpatient clinics between January 2016 and June 2022 for overactive bladder unresponsive to anticholinergic therapy Baseline symptoms and quality of life data were compared to those at month 6 after the treatment The voiding diary for 3 days of each patient was reviewed to assess and record patients symptoms Baseline ultrasound US-measured post-void residual urine PVR and bladder wall thickness BWT values were recorded Patients with a history of neurological disorders anticholinergic-naive patients patients diagnosed with bladder cancer and those with bladder outlet obstruction were excluded from the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None